298 related articles for article (PubMed ID: 24116006)
1. Altered expression of two-pore domain potassium (K2P) channels in cancer.
Williams S; Bateman A; O'Kelly I
PLoS One; 2013; 8(10):e74589. PubMed ID: 24116006
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of two-pore domain potassium channels in rat cerebellar granule neurons.
Burgos P; Zúñiga R; Domínguez P; Delgado-López F; Plant LD; Zúñiga L
Biochem Biophys Res Commun; 2014 Oct; 453(4):754-60. PubMed ID: 25305496
[TBL] [Abstract][Full Text] [Related]
3. Contribution of two-pore K
Chai S; Wan X; Nassal DM; Liu H; Moravec CS; Ramirez-Navarro A; Deschênes I
Am J Physiol Heart Circ Physiol; 2017 Jun; 312(6):H1144-H1153. PubMed ID: 28341634
[TBL] [Abstract][Full Text] [Related]
4. Segment-specific expression of 2P domain potassium channel genes in human nephron.
Levy DI; Velazquez H; Goldstein SA; Bockenhauer D
Kidney Int; 2004 Mar; 65(3):918-26. PubMed ID: 14871411
[TBL] [Abstract][Full Text] [Related]
5. Stretch-activated two-pore-domain (K
Schmidt C; Wiedmann F; Kallenberger SM; Ratte A; Schulte JS; Scholz B; Müller FU; Voigt N; Zafeiriou MP; Ehrlich JR; Tochtermann U; Veres G; Ruhparwar A; Karck M; Katus HA; Thomas D
Prog Biophys Mol Biol; 2017 Nov; 130(Pt B):233-243. PubMed ID: 28526353
[TBL] [Abstract][Full Text] [Related]
6. Atrial fibrillation and heart failure-associated remodeling of two-pore-domain potassium (K
Wiedmann F; Schulte JS; Gomes B; Zafeiriou MP; Ratte A; Rathjens F; Fehrmann E; Scholz B; Voigt N; Müller FU; Thomas D; Katus HA; Schmidt C
Basic Res Cardiol; 2018 Jun; 113(4):27. PubMed ID: 29881975
[TBL] [Abstract][Full Text] [Related]
7. Two-Pore-Domain Potassium (K
Wiedmann F; Frey N; Schmidt C
Cells; 2021 Oct; 10(11):. PubMed ID: 34831137
[TBL] [Abstract][Full Text] [Related]
8. Monoterpenes Differently Regulate Acid-Sensitive and Mechano-Gated K
Arazi E; Blecher G; Zilberberg N
Front Pharmacol; 2020; 11():704. PubMed ID: 32508645
[TBL] [Abstract][Full Text] [Related]
9. Regulation of two-pore-domain (K2P) potassium leak channels by the tyrosine kinase inhibitor genistein.
Gierten J; Ficker E; Bloehs R; Schlömer K; Kathöfer S; Scholz E; Zitron E; Kiesecker C; Bauer A; Becker R; Katus HA; Karle CA; Thomas D
Br J Pharmacol; 2008 Aug; 154(8):1680-90. PubMed ID: 18516069
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiological Role of K
Lee LM; Müntefering T; Budde T; Meuth SG; Ruck T
Cell Physiol Biochem; 2021 Mar; 55(S3):65-86. PubMed ID: 33667332
[TBL] [Abstract][Full Text] [Related]
11. Protein and Chemical Determinants of BL-1249 Action and Selectivity for K
Pope L; Arrigoni C; Lou H; Bryant C; Gallardo-Godoy A; Renslo AR; Minor DL
ACS Chem Neurosci; 2018 Dec; 9(12):3153-3165. PubMed ID: 30089357
[TBL] [Abstract][Full Text] [Related]
12. A "Target Class" Screen to Identify Activators of Two-Pore Domain Potassium (K2P) Channels.
McCoull D; Ococks E; Large JM; Tickle DC; Mathie A; Jerman J; Wright PD
SLAS Discov; 2021 Mar; 26(3):428-438. PubMed ID: 33375888
[TBL] [Abstract][Full Text] [Related]
13. A role for two-pore potassium (K2P) channels in endometrial epithelial function.
Patel SK; Jackson L; Warren AY; Arya P; Shaw RW; Khan RN
J Cell Mol Med; 2013 Jan; 17(1):134-46. PubMed ID: 23305490
[TBL] [Abstract][Full Text] [Related]
14. Physiological roles of heteromerization: focus on the two-pore domain potassium channels.
Khoubza L; Chatelain FC; Feliciangeli S; Lesage F; Bichet D
J Physiol; 2021 Feb; 599(4):1041-1055. PubMed ID: 33347640
[TBL] [Abstract][Full Text] [Related]
15. Endocytosis as a mode to regulate functional expression of two-pore domain potassium (K₂p) channels.
O'Kelly I
Pflugers Arch; 2015 May; 467(5):1133-42. PubMed ID: 25413469
[TBL] [Abstract][Full Text] [Related]
16. Murine K2P5.1 Deficiency Has No Impact on Autoimmune Neuroinflammation due to Compensatory K2P3.1- and KV1.3-Dependent Mechanisms.
Bittner S; Bobak N; Hofmann MS; Schuhmann MK; Ruck T; Göbel K; Brück W; Wiendl H; Meuth SG
Int J Mol Sci; 2015 Jul; 16(8):16880-96. PubMed ID: 26213925
[TBL] [Abstract][Full Text] [Related]
17. The Pharmacology of Two-Pore Domain Potassium Channels.
Kamuene JM; Xu Y; Plant LD
Handb Exp Pharmacol; 2021; 267():417-443. PubMed ID: 33880623
[TBL] [Abstract][Full Text] [Related]
18. Molecular Pharmacology of K
Decher N; Rinné S; Bedoya M; Gonzalez W; Kiper AK
Cell Physiol Biochem; 2021 Mar; 55(S3):87-107. PubMed ID: 33667333
[TBL] [Abstract][Full Text] [Related]
19. New Targets for Old Drugs: Cardiac Glycosides Inhibit Atrial-Specific K
Schmidt C; Wiedmann F; Gaubatz AR; Ratte A; Katus HA; Thomas D
J Pharmacol Exp Ther; 2018 Jun; 365(3):614-623. PubMed ID: 29643254
[TBL] [Abstract][Full Text] [Related]
20. [Cardiac two-pore-domain potassium channels (K2P): Physiology, pharmacology, and therapeutic potential].
Schmidt C; Wiedmann F; Schweizer PA; Katus HA; Thomas D
Dtsch Med Wochenschr; 2012 Aug; 137(33):1654-8. PubMed ID: 22875694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
